October 31. 2008

• US survey shows levofloxacin is still very active against multidrug-resistant S. pneumoniae
• GLOBAL surveillance program confirms the continuing high susceptibility of S. pneumoniae, H. influenzae and M. catarrhalis to levofloxacin

October 27. 2008

• Levofloxacin recommended for H. pylori after first intent treatment failure
• First case of Elizabethkingia miricola sepsis treated successfully with levofloxacin and tigecycline
• Rhodococcus equi infection responds to levofloxacin and amikacin

October 17. 2008

• Gatifloxacin (TEQUIN) was withdrawn from sale
• Fluoroquinolones proposed as a better treatment for typhoid and paratyphoid fever
• Levofloxacin proposed for cataract surgery prophylaxis

October 14. 2008

• New methods allow determination of levofloxacin and ornidazole in combined dosage forms
• New Japanese method for determination of levofloxacin and ofloxacin to detect distribution of counterfeit drugs

October 7. 2008

• Low rates of fluoroquinolone-resistant E. coli in patients with uncomplicated pyelonephritis
• Advice on how to curb the emergence of levofloxacin resistance

Return to Quinolones News Index